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Influence of silver nanoparticles on growth
and health of broiler chickens after
infection with Campylobacter jejuni
Krishna Prasad Vadalasetty1, Charlotte Lauridsen2, Ricarda Margarete Engberg2, Radhika Vadalasetty1,
Marta Kutwin3, André Chwalibog1,3* and Ewa Sawosz3
Abstract
Background: Silver nanoparticles (AgNP) have gained much attention in recent years due to their biomedical
applications, especially as antimicrobial agents. AgNP may be used in poultry production as an alternative to the
use of antibiotic growth promoter. However, little is known about the impact of oral administration of AgNP on
the gut microbiota and the immune system. The aim of the present study was to investigate the effects of AgNP
on growth, hematological and immunological profile as well as intestinal microbial composition in broilers challenged
with Campylobacter jejuni (C. jejuni).
Results: AgNP did not affect the intestinal microbial profile of birds. The body weight gain and the relative weights of
bursa and spleen were reduced when supplemented with AgNP. There was no difference with respect to packed cell
volume. However, the plasma concentrations of IgG and IgM were lower in birds receiving AgNP compared to the
non-supplemented control group. The expression of TNF-α and NF-kB at mRNA level was significantly higher in birds
receiving AgNP.
Conclusions: The application of AgNP via the drinking water in the concentration of 50 ppm reduced broiler growth,
impaired immune functions and had no antibacterial effect on different intestinal bacterial groups, which may limit the
applicability of AgNP against C. jejuni in broiler chickens.
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Background
In broiler production, different kinds of antimicrobial
agents are used for preventing and controlling diseases.
Antimicrobials can affect the host intestinal flora, by
reducing the colonization of intestinal bacteria, inhibiting
the growth of pathogenic microorganisms, and enhancing
the immune system, hence preventing diseases and improv-
ing animal performance [1–3]. However, the overuse of
antimicrobial agents (antibiotics) promotes the emergence
of antibiotic resistance in microorganisms [4], being harmful
to animal and human health [5, 6]. For example, resistance
to ciprofloxacin in Camplylobacter jejuni (C. jejuni) isolated
from Danish broiler meat increased significantly from 0% in
2009 to 17% in 2010 [7]. The use of all antibiotics as growth
promoter has been prohibited in the European Union since
2006 [2, 8]. Thus, there is a need to find alternatives to
antibiotics in poultry production. When the conventional
therapies, including antibiotics, anti-inflammatory agents,
growth hormones, surgical interventions, and cytotoxic
chemotherapies are ineffective in curing poultry infec-
tions, it is necessary to explore novel drug compounds.
Nanoparticles have been emerging as one of the new
treatment options, and their capability of penetrating
normally intact physiologic barriers has reached a variety
of molecular targets [9, 10].
Recent studies on antibacterial materials such as various
natural (oils, acids), inorganic antimicrobial agents such as
metals (Ag, Au, Cu) and metal oxides (ZnO, SiO2, Fe2O3,
TiO2) have received increasing attention. Among metal
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nanoparticles, silver is one of the most promising compo-
nents in several nanotechnology products. Currently, there
are several consumer products containing various silver
nanoparticles (AgNP) because of their antimicrobial prop-
erties [11–14]. AgNP have been shown to have a wide
range of antibacterial activities against both Gram-positive
and Gram-negative bacteria, including major foodborne
pathogens [15–19]. At present, there is no study available
on their antibacterial effect against C. jejuni being a leading
cause of human gastroenteritis worldwide. It is mainly
transmitted from contaminated chicken meat. Campylobac-
ter infections are associated with the neurological disorder
Guillain-Barre syndrome [20, 21]. A common feature of
C. jejuni causes enterocolitis and is involved in acute
inflammatory response that can lead to tissue damage
and may be responsible for many of the clinical symptoms
[22]. Furthermore, antimicrobial resistance was observed
in C. jejuni and Campylobacter coli [23].
Although the antimicrobial effect of AgNP has been
studied extensively, the mechanism of antibacterial activity
specific to bacteriostatic or bactericidal activity remains
unclear. Studies had shown that AgNP upon contact with
water can release Ag + ions from their surface [24]. Free
Ag + has a potent antimicrobial effect, which destroys
microorganisms immediately by blocking the cellular
respiration and disrupting the function of bacterial cell
membranes. This occurs when Ag + binds to tissue pro-
teins, causing structural changes in the bacterial cell
membranes which, in turn, cause cell death. Essential
protein complexes of the bacterial electron transport
chains are located on the cell exterior and, therefore,
are manageable for inactivation by reactive silver ions.
Ag + also binds and denatures the bacterial DNA and
RNA, thus inhibiting cell replication [25]. Recently, evi-
dence has been obtained suggesting that silver nanoparti-
cles may modulate the phosphotyrosine profile of putative
bacterial peptides that could affect cellular signaling and,
therefore, inhibit the growth of bacteria [26].
In recent years, several studies have been focused on
anti-inflammatory therapy and on molecules which could
block pro-inflammatory pathways. Nanoparticles of Ag
and Au are considered anti-inflammatory agents or
components of anti-inflammatory molecules [27, 28].
Moreover, in vivo studies with chicken embryos and
quails showed that AgNP did not affect growth, develop-
ment [29] and DNA oxidative damage to chicken embryos
[30]. Results from toxicological assays have shown no in
vitro cytotoxicity of AgNP (0.1, 0.5 and 1.0%) [17] but con-
centrations (2.5–50 μg/mL) of AgNP exert a cytotoxicity ef-
fect on human mesenchymal stem cells [31]. The most
common health effects associated with chronic exposure to
silver are a permanent grey or blue-grey discoloration of the
skin (argyria). From the immunological perspective, it is
known that phagocytosis of AgNP stimulates inflammatory
signaling through the generation of reactive oxygen species
(ROS) in macrophage cells, followed by the activated macro-
phage cell-induced secretion of TNF-α. The increase of
TNF-α level causes damage to the cell membrane and apop-
tosis [32]. An inadvertent recognition of AgNP as a foreign
particle by the immune cells may result in a multilevel
immune response and finally lead to toxicity in the host.
However, when the AgNP are recognized as self or an ab-
sence of immune recognition, then their ability to stimulate
immune response may decide the fate of AgNP in the host.
In vivo studies have demonstrated that nanoparticles are
capable of promoting inflammation or suppressing immune
functions [33–35]. The nanoparticle-induced inflammatory
response may have an impact on immune defense, and the
T-helper 1 (Th1)/T-helper 2 (Th2) balance [9, 36].
There are limited data regarding the effect of orally
administered AgNP on the intestinal bacterial popula-
tion and immune system of animals. In this study, we
hypothesized that the antimicrobial properties of colloidal
solutions of AgNP may affect the microbial population
and immune responses upon challenge. The use of AgNP
in poultry production may potentially function as an alter-
native to the use of antibiotic based growth promoters.
The objective of this study was to investigate the effect of
AgNP on the growth, the microbial profile of digestive
tract and the immune status of broilers exposed to C.
jejuni infection. In this study, we used hydrocolloid of
AgNP because they exhibit high surface/volume ratio
which may effectively enhance the bactericidal activity.
In addition, chicks were used as an animal model for
bacterial GI infection.
Methods
Experimental solution
The hydrocolloid of AgNP obtained from Nano-Tech
(Warsaw, Poland) was produced by an electric non-
explosive patented method (Polish Patent 3,883,399) from
high purity metals (99.9999%) and high purity deminera-
lized water. The concentration of the hydrocolloid was
50 mg/kg (50 ppm). The shape and size of nanoparticles
were inspected by transmission electron microscopy
(TEM), the particles had a crystal structure with an
average size of 3.5 nm. The average surface area was
2.827 × 10−13 cm2 and the pH of the colloidal silver
solution was 7.1 to 8.1 (data provided by Nano-Tech,
Poland). Furthermore, more detailed information regarding
the applied AgNP are given by Sawosz et al., 2011 [18].
Experimental design
Ninety day-old male broiler chickens (Ross 308), obtained
from a Danish commercial hatchery (DanHatch, Vrå,
Denmark) were used. Upon arrival at the laboratory, the
birds were wing-labeled, weighed and randomly distrib-
uted to two experimental groups: control, no AgNP, and
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provided with 50 ppm of AgNP in the drinking water. Fur-
thermore, prior to the experiment antibacterial tests were
done at in vitro level.
The chickens were housed in six individual isolators with
15 birds per isolator. The room temperature was 32 °C at
the beginning of the experiment and was gradually de-
creased according to the demands of the growing chickens.
The humidity was maintained during the experiment. Over
the entire experimental period, both experimental groups
were fed the same diet as described in Table 1. Drinking
water was provided via nipple drinkers placed in the isola-
tors. Birds were inspected every day and for every 2 days
water and fed consumption were recorded. All birds had
free access to food and water.
At day 11, all chickens were weighed and cloacal swab
samples of 5 chickens per isolator were taken and exam-
ined for the presence of C. jejuni colonies for initial obser-
vation. Subsequently, two birds were randomly selected
from each treatment and killed, and then blood samples
were collected for packed cell volume (PCV) determin-
ation before samples of liver tissue were collected for gene
expression studies. Afterwards, the chickens were orally
challenged with 0.5 mL of an overnight culture of C. jejuni
(4 × 107/ mL per bird). The infection strain (DVI-sc181)
has been isolated from infected commercial broilers
and provided by the Technical University of Denmark,
National Veterinary Institute.
On days 15, 22 and 30, all chickens were weighed, and 5
chickens per isolator were randomly chosen. Blood sam-
ples were taken from the jugular vein and the chickens
were immediately sacrificed by cervical dislocation. Liver,
heart, spleen and bursa were collected, weighed and stored
at -80 °C for further analysis. Ileum and caecum were col-
lected to enumerate intestinal bacteria.
Enumeration of Campylobacter and selected groups of
intestinal bacteria
C. jejuni were enumerated in intestinal contents of ileum,
caecum and faeces from 5 chickens per isolator at each
sampling day. The samples (approximately 3 g) were
homogenized, and serially diluted in 10-fold in phosphate
buffered saline and plated on modified blood free charcoal
cefoperazone deoxycholate agar base (Oxoid, CM0739).
The plates were incubated with C. jejuni specific
growth supplements at 42 °C for 48 h under microaero-
bic conditions (5% O2, 5% CO2, 5% H2, and 85% N2).
Enterobacteria (E. coli and lactose negative enterobacteria)
were enumerated on MacConkey agar (Merck, Darmstadt,
Germany, 1.05465) incubated aerobically at 37 °C for 24 h
as described by Engberg et al. [37]. Lactic acid bacteria
(LAB) and Clostridium perfringens were counted respect-
ively on De Man Rogosa Sharpe agar (Merck, 1.10660)
incubated anaerobically at 37 °C for 48 h and tryptose
sulphite cycloserine plates (TSC-Agar, Merck, 1.11072)
incubated anaerobically at 37 °C for 24 h. Enterococci were
counted on Slanetz and Bartely plates (Merck, 1.05289)
after aerobic incubation at 37 °C for 48 h. The results are
presented as microbial number (CFU/g) in ileal/caecal or
faecal material. The detection limit was 10 2 bacteria/g.
During the experiment, water samples were collected from
the drinkers in the isolators and the antimicrobial effect of
AgNP on C. jejuni was investigated in in vitro using the
plate count method.
Hematology
Before cervical dislocation, blood was collected by punc-
ture of the jugular vein in disposable sodium heparinized
hematocrit capillary tubes (Camlamb Ltd., Cambridge,
UK). The tubes were filled up to two-thirds and sealed
with cristaseal (Hawksley, Sussex, UK). The percentage
of packed cell volume (PCV) was measured by using a
micro-hematocrit reader (Hearaeus Reader, Osterode,
Germany).
Concentrations of plasma immunoglobulins
From 5 chickens, blood samples were drawn from the
jugularis vein and were collected in heparinized tubes.
Blood samples were subsequently placed on ice, centri-
fuged at 2000 g for 10 min at 4 °C, and the plasma was
stored at −20 °C until analysis of immunoglobulins. The
concentrations of IgA, IgM and IgG were measured.
Chicken plasma specific antibodies such as IgA (Bethyl
laboratories, cat. no. E33–103), IgG (Bethyl laboratories,
cat. no. E33–104) and IgM (Bethyl laboratories, cat. no.
E33–102) concentrations were determined in diluted
samples (1:100) by enzyme-linked immunosorbent assay
Table 1 Composition of the diet for broiler chickens (g/kg)
Ingredients
Wheat 49.9
Maize 10.0
Rape seed (LL), grounded 4.00
Soybean meal (de-hulled, toasted) 29.4
Soybean oil 2.45
Calcium carbonate 0.90
Monocalcium phosphate 1.56
Sodium chloride 0.20
Natrium-bicarbonate 0.27
Lysine hydrochloride (100%) 0.25
DL-Methionine (100%) 0.35
Threonine (98%) 0.10
Vitamins and minerals
(Vitfoss, Slut, 0.5%)
0.60
Total 100
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(ELISA) using microtiter plates (NuncImmunoplate 96-well,
cat. no. 446612) as per manufacturer’s ELISA quantitation
kits (Bethyl Laboratories Inc., Montgomery, TX, USA).
Measurement of the content of specific chicken anti-
bodies was done by indirect ELISA as follows: microtiter
plate wells were coated with 100 μl of diluted coating
antibody (1:200) to all wells and incubated for 2 h at
room temperature (RT). After incubation, coated plates
were washed with washing solution pH 8.0 (0.05 M Tris,
0.15 M NaCl, 10% Tween 20) to eliminate excess capture
antibodies. Wells were incubated with 200 μl blocking
buffer pH 8.0 (0.05 M Tris, 0.15 M NaCl, 1% BSA) on a
shaker for 30 min at RT to block nonspecific protein bind-
ing and then washed 3 times with washing solution.
For the determination of immunoglobulins (IgG, IgM,
or IgA), plasma samples were diluted and 100 μl of
diluted plasma was added in triplicate. Plasma dilutions
were 1:3000 for IgM, 1:1000 for IgA and 1:25,000 for
IgG. Concentrations of IgG, IgM, and IgA in the standards
were 6.25 mg/ml, 0.4 mg/ml, and 0.38 mg/ml respectively.
Standards were diluted for IgG ranging from 200 ng/ml to
3.12 ng/ml, for IgM from 250 ng/ml to 3.9 ng/ml and for
IgA from 1000 ng/ml to 15,625 ng/ml. The concentrations
of immunoglobulins in test plasma samples were deter-
mined using these standard curves. The plates were incu-
bated for 1 h at RT and were washed three times in washing
solution. 100 μl of (horseradish-peroxidase) HRP detection
anti-chicken IgM (A30-102P) was diluted 1:75,000 and for
anti-chicken IgA (A30-103P) and IgG (A30-104P) were
diluted 1:50,000 in conjugate diluent pH 8 (0.05 M Tris,
0.15 M NaCl, 10% Tween 20) was added to each well and
the plates were allowed to incubate for 1 h at RT. After
incubation, to remove unbound peroxidase-conjugates, each
well was washed with washing solution for 3 times. 100 μl
of (3,3,5,5-tetramethylbenzidine) TMB substrate was added
to each well to determine bound peroxidase, and after incu-
bation for 5–15 min in the dark at RT, 100 μl of 1 M H2SO4
was added to each well to stop the TMB reaction. The
optical density was measured at 450 nm and expressed as
ng of IgA, IgM and IgG per ml of plasma with a microplate
reader. Using the mean absorbance value for each sample,
determines the corresponding concentration of immuno-
globulins in ng/ml from the standard curve.
Gene expression of TNF-α and NF-kB
Liver tissue samples (approximately 30 mg) were homoge-
nized in TRIzol® Reagent (Invitrogen, Carlsbad CA, USA,
cat. no. 15596–018). Then, RNA clean-up was performed
and total RNA was extracted according to the manufac-
turer’s protocol using SV Total RNA isolation system (Pro-
mega Corporation, Madison, WI, USA, cat. no. Z3105).
Final RNA preparations were resuspended in RNase-free
water and stored at -80 °C. The content of isolated RNA
was quantified by UV-spectroscopy at 260 nm/280 nm with
a NanoDrop® ND-1000 Spectrophotometer (Thermo
Fisher Scientific, Waltham, MA, USA). Further quality
was assessed by Agilent 2100 bioanalyser (Agilent RNA
6000 Nano kit, Waldbronn, Germany) and more than
6.5 RNA integrity number values were considered for
cDNA preparation.
Two mg of total RNA was reverse-transcribed using
the cDNA Reverse Transcription Kit (Promega, cat. no.
A3500) in a G-storm PCR System. After this, real-time
PCR was performed with complementary DNA and gene-
specific primer pairs (TAG, Copenhagen A/S, Copenhagen,
Denmark) mixed with LightCycler®480 SYBR Green I
Master mix (Roche Applied Science, Penzberg, Germany)
in a LightCycler® 480 real-time PCR system (Roche
Applied Science). The cycling conditions included an
initial heat step at 95 °C for 5 min, denaturation at 95 °C
for 10 s, annealing temperatures described in Table 2 for
each of the primers and product elongation at 72 °C for
20 s for 45 cycles. Following amplification, the melting
curve was conducted on each sample to ensure that a
single product was obtained using three-segment cycle
of 95 °C for 5 s, 65 °C for 1 min and 95 °C no hold for
continuous-acquisition mode with a heating rate of
0.11 °C/s and 5 acquisitions per 1 °C). Characterization
of the product size was, furthermore, confirmed by
agarose gel electrophoresis and sequencing (Bechman
coulter genomics Takeley, UK). Results were quantified
based on the relative expression of the TNF-α and NF-kB
genes versus the housekeeping genes GAPDH and ACTB
using advanced relative quantification (Efficiency method)
by Light Cycler 480 Software release 1.50 SP4. The gene
expression experiment was repeated 2 times chemically
with consistent results and three replicates were used per
sample each time.
Table 2 Genes and primers used in the study
RNA target
gene
Primer sequences(5′–3′) PCR Product Gene bank
Assess. No
Annealing
Temperature
Amplicon
(bp)
GAPDH NM_204305.1
Forward TGCTGCCCAGAACATCAT 61 °C 199
Reverse ATCAGCAGCAGCCTTCAC
ACTB NM_205518.1
Forward GTCCACCTTCCAGCAGATGT 60 °C 169
Reverse ATAAAGCCATGCCAATCTCG
NF-kB M86930.1
Forward TTGCTGCTGGAGTTGATGTC 60 °C 167
Reverse TTGCTGCTGGAGTTGATGTC
TNF-α NM_204267.1
Forward TTCAGATGAGTTGCCCTTCC 59 °C 150
Reverse TCAGAGCATCAACGCAAAAG
GAPDH Glyceraldehyde-3-phosphate dehydrogenase, ACTB Actin beta, NF-kB nuclear
factor kappa B, and TNF-α Tumor necrosis factor alpha
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Statistical analysis
The data were analyzed using the GLM procedure of
SAS (SAS Institute Inc., 2008) 9.2 version for windows
considering the treatments (AgNP vs. non-supplemented
control), the day of age (15, 22 and 30) and interactions
between treatment and age. Tukey-Kramer significant
different test was employed to test the separation of the
means and differences were considered statistically signifi-
cant when the p ≤ 0.05.
Results
Enumeration of bacteria
There were no differences between birds receiving AgNP
and the control group (Fig. 1) with respect to the numbers
of C. jejuni, lactic acid bacteria, Enterococci, Clostridium
perfringens, Escherichia coli, and Lactose negative entero-
bacteria in the contents of caecum, ileum and feces of the
birds.
The influence of AgNP on feed and water intake
AgNP had no effect on the average daily water intake
(ADWI), average daily feed intake (ADFI) and feed
conversion ratio (FCR =ADFI/ ADWG) (Table 3). The
average daily weight gain (ADWG) was significantly lower
in birds receiving AgNP compared to the control birds, in
the periods 0–11 days (p = 0.007), 11–15 days (p = 0.002)
15–22 days (p = 0.003) but not in 22–30 days (p = 0.728).
The average amount of AgNP which single chicken re-
ceived in the drinking water was 8.26 mg/d (Additional file 1:
Table S1).
The effect AgNP on chicken body weight and relative
organ weights
The body weight of birds supplemented with AgNP was
significantly lower than that of control bids (Table 4).
Significant interactions between age and treatment were
observed for the relative weight of bursa and spleen,
where a lower relative bursa at age 15, and for spleen at
age 30 were noticed for AgNP group. Relative organ
weights of heart and liver were not different between the
control birds and birds supplemented with AgNP.
AgNP response on PCV
At days 15, 22 and 30 of age no significant difference
between control birds and birds receiving AgNP was
observed with respect to blood PCV levels (Fig. 2). Like-
wise, no effect of age was observed.
Plasma immunoglobulin concentrations
We observed significant interactions between treatment
and age for the concentrations of IgA, IgG and IgM in
plasma (Fig. 3). At day 30, the plasma concentration of
IgA was higher in birds supplemented with AgNP than in
control birds, whereas the opposite effect was observed at
age 15 and 22 days (p = 0.05, Fig. 3a). At day 30, the
concentration of IgG in plasma was significantly lower in
birds receiving AgNP as compared to the control birds
(Fig. 3b). At age 15, plasma concentrations of IgM were
higher in the AgNP group than in the control group
(Fig. 3c), whereas at day 22 and 30, the concentrations of
IgM were lower (p < 0.05).
Gene expression of NF-kB and TNF-α
The influence of AgNP on the mRNA NF-κB and TNF-α
expression in liver tissue of C. jejuni infected chickens is
shown in Fig. 4. Interestingly, at day 30, the levels of
NF-κB (Fig. 4a-c) and TNF-α expression (Fig. 4b-d) were
increased (p < 0.05) in the group supplemented with
AgNP compared to the control group.
Fig. 1 Influence of AgNP administration in broiler chickens after challenge with C. jejuni on microbial profile in caeca, ileum and feces. At 15, 22,
and 30 days of age, samples (n = 30 for each time point) were used for microbial count. Error bars represent the mean and standard errors of 6
isolators each with 15 birds
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Discussion
In vitro antibacterial tests against C. jejuni showed a
minimal inhibitory concentration of AgNP at the level of
40 and 50 ppm. AgNP have an effect on the target
microorganism in the absence of chickens. In the
present in vivo experiment, 50 ppm of AgNP was used
because, prior to this experiment we carried out dose
response studies to examine the antibacterial effect against
C. jejuni of different concentrations of AgNP on chickens
by chicken intestinal organ culture model (CIOC-model,
Additional file 2: Table S2). The minimum inhibitory and
minimum bactericidal concentration of silver nanoparti-
cles on C. jejuni was determined by using the microtiter
plate method (Additional file 3: Figure S1), showed bac-
tericidal effect with minimum concentration of 50 ppm.
We have evaluated samples of ileum, caecum and feces
because of the uniformity of the gut microbiota in these
segments. The caecum has a slow digesta passage rate,
allowing to harbor a complex microbiome that has
considerable effects on host nutrition and health [38]. The
small intestinal region of the ileum has received attention
since it is the principal site of nutrient absorption and
microflora [39]. Furthermore, we focused on test samples at
various time points because the caecal and ileal microflora
changes in relation to age and dietary treatments [38, 39].
However, unexpectedly, AgNP did not change the
microbial profile of caecum, ileum and feces of examined
chickens (Fig. 1). These results are consistent with in vivo
experiments with the microbial profile of young quails
receiving hydrocolloids of AgNP administered with 5, 15
and 25 ppm [29]. Moreover, another study demonstrated
that supplying AgNP did not effectively rescue Salmonella-
mediated mortality in chickens but nanoscale silicate
platelet (NSP) and its nanohybrid composite of AgNP/NSP
effectively controlled the infection [40]. However, our
present study was not similar with this study in terms of
end point of examination, concentration of nanoparticles,
bacterial infection time points and target bacterial species.
The factors that could affect the present results might be
the method of AgNP administration, although C. jejuni
colonization in the intestinal tract depends on the number
and diversity of environmental microorganisms, as well as
influence of feedstuffs. The other possibilities could be the
C. jejuni biofilm formation and adhesion to the host intes-
tinal wall may provide protection against nanoparticles.
The chicken intestinal mucus is able to attenuate C. jejuni
virulence by inhibiting its ability to adhere and invade
intestinal epithelial cells [41]. Furthermore, the antibacterial
Table 3 Effect of silver nanoparticles (AgNP) on daily feed and
water intake, weight gain and feed conversion ratio of chickens
infected with C. jejuni
Parameters Mean Pooled Treatment*Age
(g/bird) Control AgNP SE p-value
ADWI
Day 0–30 161 165 0.34 0.64
ADFI
Day 0–30 97.0 102 0.17 0.16
ADWG
Day 0–11 21.7a 18.7b
Day 11–15 43.7a 38.6b
Day 15–22 62.7a 57.4b
Day 22–30 70.5 69.4
Day 0–30 46.6 44.9 0.03 0.34
FCR
Day 0–30 1.97 2.22 0.04
*Indicates interaction
Values are mean of 6 isolators each with 15 birds
SE pooled standard error, ADWI Average daily water intake (g per bird), ADFI
Average daily feed intake (g per bird), ADWG Average daily weight gain (g per
bird) and FCR Feed conversion ratio
a,b values within rows with different superscripts are significantly different at
p <0.05
Table 4 Effects of silver nanoparticles (AgNP) on cumulative
body and relative organ weight gain (g/kg) in C. jejuni infected
broiler chickens
Parameters
(g/bird)
Mean Pooled Treatment*Age
Control AgNP SE p-value
AWG
Age 15 380a 318b
Age 22 788a 722b
Age 30 1424a 1346b 0.305 0.013
Heart
Age 15 0.71 0.70
Age 22 0.62 0.66
Age 30 0.47 0.50 9.17 0.340
Bursa
Age 15 0.25 a 0.20b
Age 22 0.21 0.22
Age 30 0.20 0.20 5.08 0.003
Spleen
Age 15 0.09 0.11
Age 22 0.07 0.07
Age 30 0.07a 0.05b 2.31 <0.001
Liver
Age 15 2.71 2.82
Age 22 2.52 2.56
Age 30 2.01 2.00 0.003 0.657
Abnormalities At age 30, big gall bladder was found from 2 out of 15
birds in AgNP group
*Indicates interaction
a, b values within rows with different superscripts are significantly different
at p <0.05. SE – pooled standard error, AWG – average body weight gain.
The relative organ weights (weight of organ/100 g live body weight). Values
are mean of 6 isolators each with 15 birds
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properties of AgNP could vanish inside the digestive tract
environment of chickens, probably, due to AgNP agglomer-
ation in the presence of low pH gastric acid. The obtained
results may suggest that AgNP were gastro-sensitive, the
stability and dispersion of AgNP in gastric acid is a critical
factor for antibacterial activity. Once the particle enters a
biological system, physical properties such as solubility,
particle agglomeration, surface charge and particle-protein
complex interactions might be different from those of
the in vitro-measured properties. The loss of nanoparticles’
properties may be due to the low colloidal stability and the
reduction of reactive surfaces may affect the efficacy for
controlling pathogens in a solution [42].
The reduction in cumulative body weight and relative
organ weights of the spleen and bursa of birds supple-
mented with AgNP might be due to the effect of AgNP
blocking the intestinal absorption of actively transported
sugars and amino acids, and decreased protein digestibility
through the small intestine where mainly enzymatic activity
is present. Another possible reason might be the fact that
the birds undergo more cellular stress and excessive
cellular interactions with AgNP. It appears that C.
jejuni colonization may lead to weight loss in grower
chickens. The present results are consistent with de-
creased body and organ weights in chickens treated
with 25 ppm of AgNP at 42 days of age [43]. Moreover,
the study of Asharani et al. [44] suggested that AgNP
increase ROS production and interrupt ATP synthesis,
leading to DNA damage and cell cycle arrest at G2/M
phase. Park et al. [32] found that AgNP induce G1
phase arrest and a complete blockage of the S phase,
with the induction of apoptosis. The AgNP (10 ppm)
injected into fertilized eggs on days 5, 11 and 17 of in-
cubation did not influence the development of embryos
Fig. 2 Effect of silver nanoparticles (AgNP) on packed cell volume
levels in chickens infected with C. jejuni. Error bars represent the
mean values and standard errors of 6 isolators each with 15 birds
a
IgA
IgM
IgG
c
b
Fig. 3 Concentration of immunoglobulins (IgA, IgG and IgM) in chickens infected with C. jejuni Samples were analyzed at days 15, 22 and 30 of
age; a) IgA b) IgG and c) IgM. Error bars represent the mean values and standard errors of 6 isolators, each with 15 birds. Interactions between
treatment and age effect significantly (p < 0.05). * Indicates significant difference between control and AgNP (p < 0.05)
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but decreased the number and size of lymph follicles in
the bursa of Fabricius [45].
The PCV results indicated that the provision of AgNP
did not influence the percentage of red blood cells (Fig. 2).
On the other hand, it was reported that the oral adminis-
tration of AgNP induced some changes in the red blood
compartment, such as increased red blood cell count [46]
and coagulation parameters [47].
The present results demonstrated age-related differ-
ences in immunoglobulin concentrations, which could
probably be ascribed to the infection with C. jejuni on day
11 of age. Immunoglobulins are generally associated with
immune resistance to extracellular bacteria and viruses or
other foreign substances. Therefore, their levels might be
most appropriate to study diseases caused by extracellular
microorganisms [48]. Plasma immunoglobulin levels were
measured following C. jejuni infection of chickens on days
15, 22 and 30 of age. Noticeable, significantly lower levels
of IgG and IgM were observed in AgNP supplemented
chickens (Fig. 3b-c). The decrease in the levels of IgG
and IgM in AgNP birds might be due to the microbial
colonization and provision of AgNP via drinking water.
Importantly, the impaired T–cell function might be a
reason for reduced IgG levels. AgNP might impair intestinal
actively transported sugars, amino acids, trace elements,
and vitamins, and deficiencies of these nutrients may
decrease antibody formation. Similar observations showed
decreased plasma IgG levels in chickens treated with
10 ppm and 20 ppm AgNP but not infected with C.
jejuni [49]. Reduction of bursa and spleen weights may
be correlated to the decreased IgG levels. Therefore,
the expression of immunological effects in this study
was assumed to be the result of AgNP impairment. It
could be that lymphocyte production and self- or non-
self-antigen selection against C. jejuni infection changes
with age, and could also be influenced by AgNP. Our
results suggested that AgNP can diminish the activity
of humoral immunity of broiler chickens by decreasing
the levels of immunoglobulins in plasma.
In the present study, NF-kB and TNF-α expression
was determined in chicken liver tissue to evaluate
whether or not AgNP could modify inflammation at the
transcriptional level (Fig. 4). NF-κB and TNF-α expres-
sions are important in Campylobacter colonization as C.
jejuni primarily colonized the lower small intestine and
caecum, where remarkable histopathologic and ultra-
structural changes in the epithelium were noticed. In a
novel rabbit model, the pathogen induced intestinal in-
flammation had increased levels of IFN-γ, TNF-α, IL-1β,
IL-2, IL-6, IL-8, and IL-22 gene expression. In the acute
a b
c d
Fig. 4 The expression of mRNA NF-κB and TNF-α normalized to the housekeeping genes ACTB and GAPDH in the liver tissue of chickens infected
with C. jejuni. Samples were analyzed at days 15, 22 and 30 of age; a) NF-κB /ACTB, b) TNF-α /ACTB, c) NF-κB /GAPDH and d) TNF-α /GAPDH. Error
bars represent the mean values and standard errors of 6 isolators, each with 15 birds. Interactions between treatment and age effect significantly
(p < 0.05). * Indicates significant difference between control and AgNP (p < 0.05)
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phase, the bacteria induced a significant increase in the
expression of the most pro-inflammatory genes [50].
The infection of human intestinal epithelium with Cam-
pylobacter results in activation of NF-kB, which is needed
for the induction of pro-inflammatory genes [51]. We
have recently observed that TNF-α mRNA expression was
consistent with 50 ppm when AgNP were injected into
chicken embryos after LPS stimulation during the 19th
day [52]. Results concerning the mRNA expression of
NF-kB were not in agreement with those of the chicken
embryo liver [53]. We suppose that this could be due to
the time of exposure, tissue specificity and route of
administration of AgNP. However, our results confirm
the pro-inflammatory activity of AgNP, which has been
previously observed in chickens and mice [54, 55]. Further-
more, an increased inflammatory response of the AgNP
group in comparison with the control group indicates an
over-immunostimulation activity of AgNP. The ability of
nanoparticles to freely move into local lymphoid tissues
and trigger antigen-presenting cells might be responsible
for their immunostimulatory activity.
The exact mechanism and reason how and where
AgNP induce pro-inflammatory effects are not known,
but it has been reported that they stimulate production
of reactive oxygen species (ROS), and thereby modulate
intracellular calcium concentrations, activate transcription
factors, and induce cytokine production [56]. The toxicity
of nanoparticles is manifested by inflammation resulting
from oxidative stress [57–59]. Recently, various studies
with AgNP have been published, demonstrating conflicting
results that silver nanoparticles are toxic [44, 59–63] or
non-toxic [64–66]. Furthermore, they could be pro-
inflammatory [47, 67–69] or anti-inflammatory agents
[27, 28, 65]. Importantly, particle size-dependent effects
of AgNP were observed with respect to cellular uptake,
pro-inflammatory response and changes at the proteome
level [70]. The 20 nm AgNP elucidated a higher inflamma-
tory response than the 200 nm particles in Caco-2/TC7
cells. It might be that bigger particles have different trans-
port rates, reduced interaction with the cellular membranes
and are better retained in the gastrointestinal epithelial
mucous layer than smaller particles. Thus, smaller particles
may cross the mucus layer and reach the cells.
An increase in mRNA expression of inflammatory
mediators and low IgG and IgM levels could be due to the
nanoparticle uptake triggering cellular effects, leading to
inflammatory responses. However, the conflicting results
might indicate that AgNP have multiple cellular targets
that vary among different cell type. These results are
attributed to several confounding factors such as pH [71],
continuous oral administration of AgNP, [47, 68] or high
concentration, [28] or even the availability of free radicals
to induce oxidative stress and damage cells [58]. We
propose that nanoparticles time of exposure, route of
administration, particles size, aggregate formation, and
altered bio-distribution in the form of rapid clearance
owing to non-specific pathogen clearance from the systemic
circulation could serve as aided factors. One possible cause
for the AgNP dependent initiation of inflammation could
be the fact that they enhance the production of ROS. These
oxygen-derived free radicals may lead to mitochondrial
dysfunction, increased gene expression of inflammatory
cytokines (TNF-α) and activation of specific transcription
factors (NF-kB). The absorption, distribution, metabolism,
excretion, and toxicity of AgNP are largely dependent on
their physicochemical properties and the surrounding
environmental conditions. However, we were unable to
find a mechanism involved in the pro-inflammatory
pathway of AgNP in the present work and could not verify
the presence of AgNP in the digestive organs.
Conclusions
Orally-administered AgNP via the drinking water (50 ppm)
had no effect on the intestinal colonization of C. jejuni
following infection and did not influence the intestinal
microbial profile of broiler chickens. However, AgNP
reduced body weight gain, lowered concentrations of
plasma immunoglobulins and upregulated mRNA expres-
sion of TNF-α and NF-kB, indicating toxicity and impaired
immune response. Thus, the use of orally administered
AgNP might be harmful to the chicken health.
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